Topics
Anesthetic Drugs & PharmacologyPhysiology & Consciousness
Series
Anesthesia Epochs
- Anton Bom and colleagues at Organon described a new concept for reversing neuromuscular block: chemically encapsulating rocuronium inside a modified cyclodextrin. This film follows a reversal agent from molecular design toward the clinic. Its selectivity also defined its limits: it binds rocuronium and vecuronium, not succinylcholine or benzylisoquinolinium blockers.
Read beyond the film
2002: The Sugammadex Concept Builds a Molecular Pocket for Rocuronium
Read the full essay, examine its references and source limitations, and follow the historical connections.
AI-assisted visual reconstructions and dramatized scenes illustrate the story; they are not archival recordings. Educational content, not individual medical advice.
